Biomimetic 3D Tissue Models for Advanced High-Throughput Drug Screening

Journal of Laboratory Automation

Volumn 20, Issue 3, 2015, Pages 201-215

  Nam, Ki Hwan ^a,b,c   Smith, Alec S T ^a   Lone, Saifullah ^b   Kwon, Sunghoon ^b   Kim, Deok Ho ^a,d  

^a University of Washington   (United States)

^b Seoul National University   (South Korea)

^c Korea Basic Science Institute (KBSI)   (South Korea)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

bio nanotechnology; biomimetic microenvironment; high throughput drug screening; microengineered 3D tissue models; organ on chip

Indexed keywords

BIOMIMETICS; DIAGNOSIS; HISTOLOGY; PHYSIOLOGY; SCREENING; SCREENS (SIZING); THREE DIMENSIONAL COMPUTER GRAPHICS; TISSUE;

3-D TISSUES; BIO-NANOTECHNOLOGIES; DRUG SCREENING; MICROENVIRONMENTS; ON CHIPS;

PHYSIOLOGICAL MODELS;

ADIPOSE TISSUE; BIOCOMPATIBILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RESEARCH; DRUG SCREENING; EXTRACELLULAR MATRIX; HEART; HIGH THROUGHPUT SCREENING; IN VITRO STUDY; IN VIVO STUDY; KIDNEY PARENCHYMA; LIVER; LUNG PARENCHYMA; MOLECULAR MODEL; MUSCULOSKELETAL SYSTEM; NANOBIOTECHNOLOGY; REGENERATIVE MEDICINE; REVIEW; SKIN CULTURE; STEM CELL; TISSUE ENGINEERING; TISSUE SCAFFOLD; ANIMAL; BIOMIMETICS; HUMAN; NANOTECHNOLOGY; ORGAN CULTURE TECHNIQUE; PRECLINICAL STUDY; PROCEDURES;

ANIMALS; BIOMIMETICS; DRUG EVALUATION, PRECLINICAL; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; NANOTECHNOLOGY; ORGAN CULTURE TECHNIQUES; TISSUE ENGINEERING;

EID: 84930240627     PISSN: 22110682     EISSN: 22110690     Source Type: Journal    
DOI: 10.1177/2211068214557813     Document Type: Review

References (123)

1. McKim J. M.Building a Tiered Approach to In Vitro Predictive Toxicity Screening: A Focus on Assays with In Vivo Relevance.Comb. Chem. HTS. 2010;13:188-206
2. May M. S.,Wardell W. M.,Lasagna L.New Drug Development during and after a Period of Regulatory Change: Clinical Research Activity of Major United States Pharmaceutical Firms, 1958 to 1979.Clin. Pharmacol. Ther. 1983;33:691-700
3. Eschenhagen T.,Zimmermann W. H.Engineering Myocardial Tissue.Circ. Res. 2005;97:1220-1231
4. Mathers C. D.,Bernard C.,Iburg K. M., et alGlobal Burden of Disease: Data Sources, Methods and Results. World Health Organization: Geneva, Switzerland; 2008:
5. Boudou T.,Legant W. R.,Mu A., et al.A Microfabricated Platform to Measure and Manipulate the Mechanics of Engineered Cardiac Tissue.Tissue Eng. Part A. 2012;18:910-919
6. Legant W. R.,Pathak A.,Yang M. T., et al.Microfabricated Tissue Gauges to Measure and Manipulate Forces from 3D Microtissues.Proc. Natl. Acad. Sci. U. S. A. 2009;106:10097-10102
7. Berthiaume F.,Maguire T. J.,Yarmush M. L.Tissue Engineering and Regenerative Medicine: History, Progress, and Challenges.Annu. Rev. Chem. Biomol. Eng. 2011;2:403-430
8. Mansbridge J. N.Tissue-Engineered Skin Substitutes in Regenerative Medicine.Curr. Opin. Biotechnol. 2009;20:563-567
9. Takahashi K.,Tanabe K.,Ohnuki M., et al.Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors.Cell. 2007;132:861-872
10. Zhang Z.,Michniak-Kohn B. B.Tissue Engineered Human Tissue Equivalents.Pharmaceutics. 2012;4:26-41
11. Karande P.,Mitragotril S.High Throughput Screening of Transdermal Formulations.Pharm. Res. 2002;19:655
12. Sullivan D. C.,Mirmalek-Sani S.-H.,Deegan D. B., et al.Decellularization Methods of Porcine Kidneys for Whole Organ Engineering Using a High-Throughput System.Biomaterials. 2012;33:7756-7764
13. Kim P.,Yuan A.,Nam K.-H., et al.Fabrication of Poly(Ethylene Glycol): Gelatin Methacrylate Composite Nanostructures with Tunable Stiffness and Degradation for Vascular Tissue Engineering.Biofabrication. 2014;6:024112
14. Deckers M. M. L.,Van Bezooijen R. L.,Van Der Horst G., et al.Bone Morphogenetic Proteins Stimulate Angiogenesis through Osteoblast-Derived Vascular Endothelial Growth Factor A.Endocrinology. 2002;143:1545-1553
15. Kim H. S.Assignment1 of the Human Basic Fibroblast Growth Factor Gene FGF2 to Chromosome 4 Band q26 by Radiation Hybrid Mapping.Cytogenet. Cell Genet. 1998;83:73
16. Neufeld G.,Cohen T.,Gengrinovitch S., et al.Vascular Endothelial Growth Factor and Its Receptors.FASEB J. 1999;13:9-22
17. Lee K.,Silva E. A.,Mooney D. J.Growth Factor Delivery-Based Tissue Engineering: General Approaches and a Review of Recent Developments.J. R. Soc. Interface. 2011;8:153-170
18. Seliktar D.,Nerem R. M.,Galis Z. S.Mechanical Strain-Stimulated Remodeling of Tissue-Engineered Blood Vessel Construct.Tissue Eng. 2003;9:657-666
19. Gomez E. W.,Chen Q. K.,Gjorevski N., et al.Tissue Geometry Patterns Epithelial-Mesenchymal Transition via Intercellular Mechanotransduction.J. Cell Biochem. 2010;110:44-51
20. Baguneid M.,Murray D.,Salacinski H. J., et al.Shear-Stress Preconditioning and Tissue-Engineering-Based Paradigms for Generating Arterial Substitutes.Biotechnol. Appl. Biochem. 2004;39:151-157
21. Yeatts A. B.,Fisher J. P.Bone Tissue Engineering Bioreactors: Dynamic Culture and the Influence of Shear Stress.Bone. 2011;48:171-181
22. Kim D. H.,Provensano P. P.,Smith C. L., et al.Matrix Nanotopography as a Regulator of Cell Function.J. Cell Biol. 2012;197:351-360
23. Lee M. Y.,Kwon K. W.,Jung H., et al.Directed Differentiation of Human Embryonic Stem Cells into Selective Neurons on Nanoscale Ridge/Groove Pattern Arrays.Biomaterials. 2010;31:4360-4366
24. Astashkina A. I.,Mann B. K.,Prestwich G. D., et al.A 3-D Organoid Kidney Culture Model Engineered for High-Throughput Nephrotoxicity Assays.Biomaterials. 2012;33:4700-4711
25. Pathak A.,Kumar S.Transforming Potential and Matrix Stiffness Co-Regulate Confinement Sensitivity of Tumor Cell Migration.Integr. Biol. 2013;5:1067-1075
26. Patra C.,Ricciardi F.,Engel F. B.The Functional Properties of Nephronectin: An Adhesion Molecule for Cardiac Tissue Engineering.Biomaterials. 2012;33:4327-4335
27. Akins R. E.,Boyce R. A.,Madonna M. L., et al.Cardiac Organogenesis In Vitro: Reestablishment of Three-Dimensional Tissue Architecture by Dissociated Neonatal Rat Ventricular Cells.Tissue Eng. 1999;5:103-108
28. Bursac N.,Papadaki M.,Langer R., et al.Three-Dimensional Environment Promotes In Vitro Differentiation of Cardiac Myocytes.Am. J. Physiol. Heart Circ. Physiol. 1999;27:H433-H444
29. Zimmermann W.-H.,Schneiderbanger K.,Schubert P., et al.Tissue Engineering of a Differentiated Cardiac Muscle Construct.Circ. Res. 2002;90:223-230
30. Hoerstrup S.P.,Zund G.,Schnell A. M., et al.Optimized Growth Conditions for Tissue Engineering of Human Cardiovascular Structures.Int. J. Artif. Organs. 2000;23:817-823
31. Hirt M. N.,Boeddinghaus J. B.,Mitchell A., et al.Functional Improvement and Maturation of Rat and Human Engineered Heart Tissue by Chronic Electrical Stimulation.J. Mol. Cell. Cardiol. 2014;74:151-161
32. Bian W.,Badie N.,Himel H. D., et al.Robust T-Tubulation and Maturation of Cardiomyocytes Using Tissue-Engineered Epicardial Mimetics.Biomaterials. 2014;35:3819-3828
33. Takeuchi R.,Kuruma Y.,Sekine H., et al.In Vivo Vascularization of Cell Sheets Provided Better Long-Term Tissue Survival Then Injection of Cell Suspension.J. Tissue Eng. Regen. Med. in press;:
34. Zhang G.,Nakamura Y.,Wang X., et al.Controlled Release of Stromal Cell–Derived Factor-1 Alpha In Situ Increases C-kit+ Cell Homing to the Infarcted Heart.Tissue Eng. 2007;13:2063-2071
35. Gao J.,Liu J.,Gao Y., et al.A Myocardial Patch Made of Collagen Membranes Loaded with Collagen-Binding Human Cascular Endothelial Growth Factor Accelerates Healing of the Injured Rabbit Heart.Tissue Eng. Part A. 2011;17:2739-2747
36. Burridge P. W.,Anderson D.,Priddle H., et al.Improved Human Embryonic Stem Cell Embryoid Body Homogeneity and Cardiomyocyte Differentiation from a Novel V-96 Plate Aggregation System Highlights Interline Variability.Stem Cells. 2007;25:929-938
37. Yang L.,Soonpaa M. H.,Adler E. D., et al.Human Cardiovascular Progenitor Cells Develop from a KDR+ Embryonic-Stem-Cell-Derived Population.Nature. 2008;453:524-528
38. Chong J. J.,Yang X.,Don C. W., et al.Human Embryonic Stem Cell Derived Cardiomyocytes Regenerate Non-Humna Primate Hearts.Nature. 2014;510:273-277
39. Myers F. B.,Silver F. S.,Zhuge Y., et al.Robust Pluripotent Stem Cell Expansion and Cardiomyocyte Differentiation via Geometric Patterning.Integr. Biol. 2013;5:1495-1506
40. Lim S. Y.,Sivakumaran P.,Crombie D. E., et al.Trichostantin A Enhances Differentiation of Human Induced Pluripotent Stem Cells to Cardiogenic Cells for Cardiac Tissue Engineering.Stem Cells Transl. Med. 2013;9:715-725
41. Wang G.,McCain M. L.,Yang L., et al.Modeling the Mitochondrial Cardiomyopathy of Barth Syndrome with Induced Pluripotent Stem Cell and Heart-on-Chip Technologies.Nat. Med. 2014;20:616-623
42. Lu T.-Y.,Lin B.,Kim J., et al.Repopulation of Decellularized Mouse Heart with Human Induced Pluripotent Stem Cell–Derived Cardiovascular Progenitor Cells.Nat. Comm. 2013;4:3307
43. Isayama N.,Matsumura G.,Sato H., et al.Histological Maturation of Vascular Smooth Muscle Cells in In Situ Tissue-Engineered Vasculature.Biomaterials. 2014;35:3589-3595
44. Lueders C.,Sodian R.,Shakibaei M., et al.Short-Term Culture of Human Neonatal Myofibroblasts Seeded Using a Novel Three-Dimensional Rotary Seeding Device.ASAIO J. 2006;52:310-314
45. Twardowski R. L.,Black L. D.Cardiac Fibroblasts Support Endothelial Cell Proliferation and Sprout Formation but Not the Development of Multicellular Sprouts in a Fibrin Gel Co-Culture Model.Ann. Biomed. Eng. 2014;42:1074-1084
46. Zong X.,Bien H.,Chung C. Y., et al.Electrospun Fine-Textured Scaffolds for Heart Tissue Constructs.Biomaterials. 2005;26:5330-5338
47. Chen H.,Cornwell J.,Zhang H., et al.Cardiac-Like Flow Generator for Long-Term Imaging of Endothelial Cell Responses to Circulatory Pulsatile Flow at Microscale.Lab Chip. 2013;13:2999-3007
48. Tandon N.,Taubman A.,Cimetta E., et al.Portable Bioreactor for Perfusion and Electrical Stimulation of Engineered Cardiac Tissue.Conf. Proc. IEEE Eng. Med. Biol. Soc. 2013;2013:6219-6223
49. Macadangdang J.,Jiao A.,Carson D., et al.Capillary Force Lithography for Cardiac Tissue Engineering.J. Visual. Exp. 2014;88:e50039
50. Kim D. H.,Lipke E.,Kim P., et al.Nanoscale Cues Regulate the Structure and Function of Macroscopic Cardiac Tissue Constructs.Proc. Natl. Acad. Sci. U. S. A. 2010;107:565-570
51. Kim D. H.,Kshitiz,Smith R. R., et al.Nanopatterned Cardiac Cell Patches Promote Stem Cell Niche Formation and Myocardial Regeneration.Integr. Biol. 2012;4:1019-1033
52. Hansen A.,Eder A.,Bönstrup M., et al.Development of a Drug Screening Platform Based on Engineered Heart Tissue.Circ. Res. 2010;107:35-44
53. Hirt M. N.,Hansen A.,Eschenhagen T.Cardiac Tissue Engineering: State of the Art.Circ. Res. 2014;114:354-367
54. Cosgrove B. D.,Sacco A.,Gilbert P. M., et al.A Home Away From Home: Challenges and Opportunities in Engineering In Vitro Muscle Satellite Cell Niches.Differentiation. 2009;78:185-194
55. Ni P.,Fu S.,Fan M., et al.Preparation of Poly(Ethylene Glycol)/Polylactide Hybrid Fibrous Scaffolds for Bone Tissue Engineering.Int. J. Nanomed. 2011;6:3065-3075
56. Kostrominova T. Y.,Calve S.,Arruda E. M., et al.Ultrastructure of Myotendinous Junctions in Tendon-Skeletal Muscle Constructs Engineered In Vitro.Histol. Histopathol. 2009;5:541-550
57. Grace Chao P. H.,Hsu H. Y.,Tseng H. Y.Electrospun Microcrimped Fibers with Nonlinear Mechanical Properties Enhance Ligament Fibroblast Phenotype.Biofabrication. 2014;3:035008
58. Jeong C. G.,Francisco A. T.,Niu Z., et al.Screening of Hyaluronic Acid–Poly(Ethylene Glycol) Composite Hydrogels to Support Intervertebral Disc Cell Biosynthesis Using Artificial Neural Network Analysis.Acta Biomaterialia. 2014;10:3421-3430
59. Vandenburgh H.High-Content Drug Screening with Engineered Musculoskeletal Tissues.Tissue Eng. 2010;16:55-64
60. Khodabukus A.,Baar K.Regulating Fibrinolysis to Engineer Skeletal Muscle from the C2C12 Cell Line.Tissue Eng. Part C. 2009;3:501-511
61. Juhas M.,Engelmayr G. C.,Fontanella A. N., et al.Biomimetic Engineered Muscle with Capacity for Vascular Integration and Functional Maturation In Vivo.Proc. Natl. Acad. Sci. U. S. A. 2014;15:5508-5513
62. Hwang Y.,Suk S.,Lin S., et al.Directed In Vitro Myogenesis of Human Embryonic Stem Cells and Their In Vivo Engraftment.PLoS One. 2013;8:72023
63. Butler D. L.,Lewis J. L.,Frank C. B., et al.Evaluation Criteria for Musculoskeletal and Craniofacial Tissue Engineering Constructs: A Conference Report.Tissue Eng. Part A. 2008;14:2089-2104
64. Butler D. L.,Juncosa-Melvin N.,Boivin G. P., et al.Functional Tissue Engineering for Tendon Repair: A Multidisciplinary Strategy Using Mesenchymal Stem Cells, Bioscaffolds, and Mechanical Stimulation.J. Orthop. Res. 2008;26:1-9
65. Powell C. A.,Smiley B. L.,Mills J., et al.Mechanical Stimulation Improves Tissue-Engineered Human Skeletal Muscle.Am. J. Physiol. Cell Physiol. 2002;283:C1557
66. Martin N. R.,Passey S. L.,Player D. J., et al.Factors Affecting the Structure and Maturation of Human Tissue Engineered Skeletal Muscle.Biomaterials. 2013;23:5759-5765
67. Langelaan M. L.,Boonen K. J.,Rosaria-Chak K. Y., et al.Advanced Maturation by Electrical Stimulation: Differences in Response between C2C12 and Primary Muscle Progenitor Cells.J. Tissue Eng. Regen. Med. 2011;7:529-539
68. Thorrez L.,Shansky J.,Wang L., et al.Growth, Differentiation, Transplantation and Survival of Human Skeletal Myofibibers on Biodegradable Scaffolds.Biomaterials. 2008;29:75-84
69. Guex A. G.,Birrer D. L.,Fortunato G., et al.Anisotropically Oriented Electrospun Matrices with an Imprinted Periodic Micropattern: A New Scaffold for Engineered Muscle Constructs.Biomed. Mater. 2013;2:021001
70. Napolitano A. P.,Dean D. M.,Man A. J., et al.Scaffold-Free Three-Dimensional Cell Culture Utilizing Micromolded Nonadhesive Hydrogels.BioTechniques. 2007;43:494-500
71. Eastwood M.,Mudera V. C.,McGrouther D. A., et al.Effect of Precise Mechanical Loading on Fibroblast Populated Collagen Lattices: Morphological Changes.Cell Motil. Cytoskeleton. 1998;1:13-21
72. Morimoto Y.,Kato-Negishi M.,Onoe H., et al.Three-Dimensional Neuron-Muscle Constructs with Neuromuscular Junctions.Biomaterials. 2013;34:9413-9419
73. Stanton L.,Sabari S.,Sampaio A. V., et al.p38 MAP Kinase Signaling Is Required for Hypertrophic Chondrocyte Differentiation.Biochem. J. 2004;378:53-62
74. Vandenburgh H.,Shansky J.,Benesch-Lee F., et al.Drug-Screening Platform Based on the Contractility of Tissue-Engineered Muscle.Muscle Nerve. 2008;37:438-447
75. Juhas M.,Engelmayr G. C.,Fontanella A. N., et al.Biomimetic Engineered Muscle with Capacity for Vascular Integration and Functional Maturation In Vino.Proc. Natl. Acad. Sci. U. S. A. 2014;111:5508-5513
76. Ye X.,Lu L.,Kolewe M. E., et al.A Biodegradable Microvessel Scaffold as a Framework to Enable Vascular Support of Engineered Tissue.Biomaterials. 2013;34:10007-10015
77. Smith A. S.,Long C. J.,Pirozzi K., et al.A Functional System for High-Content Screening of Neuromuscular Junctions In Vitro.Technology (Signap. World Sci.). 2013;1:37-48
78. Umbach J. A.,Adams K. L.,Gundersen C. B., et al.Functional Neuromuscular Junctions Formed by Embryonic Stem Cell–Derived Motor Neurons.PLoS One. 2012;7:e36049
79. Larkin L. M.,Calve S.,Kostrominova T. Y., et al.Structure and Functional Evaluation of Tendon-Skeletal Muscle Constructs Engineered In Vitro.Tissue Eng. 2006;12:3149-3158
80. Groeber F.,Holeiter M.,Hampel M., et al.Skin Tissue Engineering—In Vivo and In Vitro Applications.Adv. Drug Deliv. Rev. 2011;128:352-366
81. Topol B. M.,Haimes H. B.,Dubertret L., et al.Transfer of Melanosomes in a Skin Equivalent Model In Vitro.J. Invest. Dermatol. 1986;87:642-647
82. Hudon V.,Berthod F.,Black A. F., et al.A Tissue-Engineered Endothelialized Dermis to Study the Modulation of Angiogenic and Angiostatic Molecules on Capillary-Like Tube Formation In Vitro.Br. J. Dermatol. 2003;148:1094-1104
83. Bechetoille N.,Dezutter-Dambuyant C.,Damour O., et al.Effects of Solar Ultraviolet Radiation on Engineered Human Skin Equivalent Containing Both Langerhans Cells and Dermal Dendritic Cells.Tissue Eng. 2007;13:2667-2679
84. Roggenkamp D.,Kopnick S.,Stab F., et al.Epidermal Nerve Fibers Modulate Keratinocyte Growth via Neuropeptide Signaling in an Innervated Skin Model.J. Invest. Dermatol. 2013;133:1620-1628
85. Metrtsching H.,Weimer M.,Kersen S., et al.Human Skin Equivalent as an Alternative to Animal Testing.GMS Krankenhaushyg. Interdiszip. 2008;3:1-4
86. Wever B. D.,Petersohn D.,Mewes K. R.Overview of Human Three-Dimensional Skin Models Used for Dermal Toxicity Assessment—Part 1.H&PC Today. 2013;8:18-23
87. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014:
88. Badylak S. F.,Weiss D. J.,Caplan A., et al.Engineered Whole Organs and Complex Tissues.Lancet. 2012;379:943-952
89. Nichols J. E.,Niles J. A.,Cortiella J.Design and Development of Tissue Engineered Lung: Progress and Challenges.Organogenesis. 2009;5:57-61
90. Samadikuchaksaraei A.,Cohen S.,Isaac K., et al.Derivation of Distal Airway Epithelium from Human Embryonic Stem Cells.Tissue Eng. 2006;12:867-875
91. Cortiella J.,Nichols J. E.,Kojima K., et al.Tissue-Engineered Lung: An In Vivo and In Vitro Comparison of Polyglycolic Acid and Pluronic F-127 Hydrogel/Somatic Lung Progenitor Cell Constructs to Support Tissue Growth.Tissue Eng. 2006;12:1213-1225
92. Wong A. P.,Keating A.,Lu W. Y., et al.Identification of a Bone Marrow–Derived Epithelial-Like Population Capable of Repopulating Injured Mouse Airway Epithelium.J. Clin. Invest. 2009;119:336-348
93. Banerjee E. R.,Laflamme M. A.,Papayannopoulou T., et al.Human Embryonic Stem Cells Differentiated to Lung Lineage-Specific Cells Ameliorate Pulmonary Fibrosis in a Xenograft Transplant Mouse Model.PLoS One. 2012;7:e33162
94. Nichols J. E.,Cortiella J.Engineering of a Complex Organ: Progress toward Development of a Tissue-Engineered Lung.Proc. Am. Thorac. Soc. 2008;5:723-730
95. Petersen T. H.,Calle E. A.,Zhao L., et al.Tissue Engineered Lungs for In Vivo Implantation.Science. 2010;329:538-541
96. Huh D.,Mattews B. D.,Mammoto A., et al.Reconstituting Organ-Level Lung Functions on a Chip.Science. 2010 1662;328:
97. DesRochers T.,Suter L.,Roth A., et al.Bioengineered 3D Human Kidney Tissue, a Platform for the Determination of Nephrotoxicity.PLoS One. 2013;8:e59219
98. Timm D. M.,Chen J.,Sing D., et al.A High-Throughput Three-Dimensional Cell Migration Assay for Toxicity Screening with Mobile Device–Based Macroscopic Imaging Analysis.Sci. Rep. 2013;3:3000
99. Lee W. J.Liver Tissue Engineering Based on Poly (Ethylene Glycol) Hydrogels. 2010;:
100. Fitzpatrick E.,Mitry R. R.,Dhawan A.Human Hepatocyte Transplantation: State of the Art.J. Intern. Med. 2009;266:339-357
101. Tsang V. L.,Chen A. L.,Cho L. M., et al.Fabrication of 3D Hepatic Tissue by Additive Photopatterning of Cellular Hydrogels.FASEB J. 2007;21:790-801
102. Domansky K.,Inman W.,Serdy J., et al.Perfused Multiwell Plate for 3D Liver Tissue Engineering.Lab Chip. 2010;10:51-58
103. Chen A. A.,Underhill G. H.,Bhatia S. N.Multiplexed, High-Throughput Analysis of 3D Microtissue Suspensions.Integr. Biol. 2010;2:517-527
104. Sudo R.Multiscale Tissue Engineering for Liver Construction.Organogenesis. 2014;10:216-224
105. Yao R.,Zhang R.,Lin F., et al.Biomimetic Injectable HUVEC-Adipocytes/Collagen/Alginate Microsphere Co-Cultures for Adipose Tissue Engineering.Biotechnol. Bioeng. 2012;110:1430-1443
106. Ward A.,Quinn K. P.,Bellas E., et al.Noninvasive Metabolic Imaging of Engineered 3D Human Adipose Tissue in a Perfusion Bioreactor.PLoS One. 2013;8:0055696
107. Virayaidya K.,Shuler M. L.Incorporation of 3T3-L1 Cells to Mimic Bioaccumulation in a Microscale Cell Culture Analog Device for Toxicity Studies.Biotechnol. Prog. 2004;20:590-597
108. Kim D.H.,Lee H.,Lee Y.K., et al.Biomimetic Nanopatterns as Enabling Tools for Analysis and Control of Live Cells.Adv. Mater. 2010;22:4551-4566
109. Kim H. N.,Kang D. H.,Kim M. S., et al.Patterning Methods for Polymers in Cell and Tissue Engineering.Annu. Biomed. Eng. 2012;40:1339-1355
110. Kim D. H.,Wong P. K.,Park J., et al.Microengineered Platforms for Cell Mechanobiology.Annu. Rev. Biomed. Eng. 2009;11:203-233
111. Jiao A.,Trosper N. E.,Yang H. S., et al.Thermoresposive Nanofabricated Substratum for the Engineering of 3D Tissues with Layer-by-Layer Architectural Control.ACS Nano. 2014;8:4430-4439
112. Marx U.,Walles H.,Hoffmann S., et al.‘Human-on-a-Chip’ Developments: A Translational Cutting-Edge Alternative to Systemic Safety Assessment and Efficiency Evaluation of Substances in Laboratory Animals and Man?.Altern. Lab. Anim. 2012;40:235-257
113. Jang K. J.,Mehr A. P.,Hamilton G. A., et al.Human Kidney Proximal Tubule-on-a-Chip for Drug Transport and Nephrotoxicity Assessment.Integr. Biol. 2013;5:1119-1129
114. Agarwal A.,Goss J. A.,Cho A., et al.Microfluidic Heart on a Chip for Higher Throughput Pharmacological Studies.Lab Chip. 2013;13:3599-3608
115. Huh D.,Torisawa Y.-S.,Hamilton G. A., et al.Microengineered Physiological Biomimicry: Organ-on-Chips.Lab Chip. 2012;12:2156-2164
116. Harrison A. P.,Erlwanger K. H.,Elbrønd V. S., et al.Gastrointestinal-Tract Models and Techniques for Use in Safety Pharmacology.J. Pharm. Toxicol. Methods. 2004;49:178-199
117. Liao D. H.,Zhao J. B.,Gregersen H.Gastrointestinal Tract Modelling in Health and Disease.World J. Gastroenterol. 2009;15:169-176
118. Sung J. H.,Yu J.,Luo D., et al.Microscale 3-D Hydrogel Scaffold for Biomimetic Gastrointestinal (GI) Tract Model.Lab Chip. 2011;11:389-392
119. Astashkina A.,Mann B.,Grainger D. W.A Critical Evaluation of In Vitro Cell Culture Models for High-Throughput Drug Screening and Toxicity.Pharmacol. Ther. 2012;134:82-106
120. Sarraf C. E.,Harris A. B.,McCulloch A. D., et al.Tissue Engineering of Biological Cardiovascular System Surrogates.Heart Lung Circ. 2002;11:142-150
121. Supp D. M.,Boyce S. T.Engineered Skin Substitutes: Practices and Potentials.Clin. Dermatol. 2005;23:403-412
122. Shakespeare P. G.The role of Skin Substitutes in the Treatment of Burn Injuries.Clin. Dermatol. 2005;23:413-418
123. Metcalfe A. D.,Ferguson M. W.Tissue Engineering of Replacement Skin: The Crossroads of Biomaterials, Wound Healing, Embryonic Development, Stem Cells and Regeneration.J. R. Soc. Interface. 2007;4:413-437